Sort
17,054 grants matching “genome editing”
Recombineering-based no-cleavage gene-editing toolkit for large-scale genome engineering and functional screening
$417,908Le Cong · Stanford University · R01 · FY2023 · GM
Towards the Development of Engineered Phage Therapeutics against MDR Pathogens
$417,895Elena M Barbu · C3 Jian, Llc · R33 · FY2018 · AI
Project 1: Elucidating the genetics and cell of origin of pancreatic cancer initiation
$417,810Laura D Attardi · Stanford University · P01 · FY2025 · CA
In vivo gene editing of hematopoietic stem and progenitor cells
$417,500Amy Jo Wagers · Joslin Diabetes Center · R01 · FY2020 · HL
In vivo gene editing of hematopoietic stem and progenitor cells
$417,500Amy Jo Wagers · Joslin Diabetes Center · R01 · FY2021 · HL
Relaxed Polymerase Pausing as a Driver of Epigenetic Plasticity and Cancer Cell Invasion
$417,469Paula M Vertino · University Of Rochester · R01 · FY2025 · CA
Project 1 High-order assembly of MegaTrans complexes for hormone-independent enhancer activation
$417,396Zhijie "jason" Liu · University Of Texas Hlth Science Center · U54 · FY2018 · CA
Mechanisms Underlying Tissue Fragility in Ectodermal Dysplasias
$417,289Maranke I. Koster · East Carolina University · R01 · FY2022 · AR
ELAVL3 in ALS/FTD
$417,259John Ravits · University Of California, San Diego · R21 · FY2021 · NS
Targeting Ischemia-Induced Dependencies on the Metabolic Stress Response in Hepatocellular Carcinoma Through Image-Guided, Locoregional Therapy
$417,256Terence P Gade · University Of Pennsylvania · R01 · FY2022 · CA
Understanding the variability in nonsense-mediated RNA decay
$417,177Sujatha Jagannathan · University Of Colorado Denver · R35 · FY2025 · GM
Advanced development of composite gene delivery and CAR engineering systems
$417,077Sidi Chen · Yale University · R33 · FY2025 · CA
CORE--HIGH PERFORMANCE WORKSTATION
$417,076Robert C Young · Fox Chase Cancer Center · P30 · FY2007 · CA
Advanced development of composite gene delivery and CAR engineering systems
$417,075Sidi Chen · Yale University · R33 · FY2023 · CA
Mechanisms regulating clathrin-mediated endocytosis
$417,068Sandra L. Schmid · Ut Southwestern Medical Center · R01 · FY2017 · GM
Mechanisms regulating clathrin-mediated endocytosis
$417,068Sandra L. Schmid · Ut Southwestern Medical Center · R01 · FY2015 · GM
Mechanisms regulating clathrin-mediated endocytosis
$417,068Sandra L. Schmid · Ut Southwestern Medical Center · R01 · FY2016 · GM
In vivo gene editing of hematopoietic stem and progenitor cells
$416,975Amy Jo Wagers · Joslin Diabetes Center · R01 · FY2019 · HL
GAA REPEATS INDUCED EPIGENETIC SILENCING IN FRIEDREICH'S ATAXIA
$416,950Marek Napierala · University Of Alabama At Birmingham · R01 · FY2019 · NS
GAA REPEATS INDUCED EPIGENETIC SILENCING IN FRIEDREICH'S ATAXIA
$416,950Marek Napierala · University Of Alabama At Birmingham · R01 · FY2018 · NS
GAA REPEATS INDUCED EPIGENETIC SILENCING IN FRIEDREICH'S ATAXIA
$416,950Marek Napierala · University Of Alabama At Birmingham · R01 · FY2020 · NS
GAA REPEATS INDUCED EPIGENETIC SILENCING IN FRIEDREICH'S ATAXIA
$416,950Marek Napierala · University Of Alabama At Birmingham · R01 · FY2017 · NS
Assessing the Strength of Weak Ties for Interpreting Human Exome
$416,948Suvobrata Chakravarty · South Dakota State University · R15 · FY2019 · GM
Discovery and therapeutic targeting of biological determinants of lung cancer health disparities
$416,907Sharon R. Pine · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA
The Role of Cardiomyocyte Polarity in Cardiac Morphogenesis
$416,850Ibrahim J Domian · Massachusetts General Hospital · R01 · FY2018 · HL